In the To901317-induced lipogenesis phase of the steatosis model in both the human and mouse cell lines, the TG accumulation was significantly suppressed by the cotreatments of FXR-ligands in accompany with the FXR-LXRα-SREBP-1c cascade. The gene discussed is NR1H4; the disease is steatosis.